CHEYENNE, WY, Sept. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – MJ Biotech, Inc. (OTC: MJTV) (FKA Michael James Enterprises, Inc.) announces the grand opening of its Ecommerce Site https://mjbiotech.myshopify.com which showcases its most popular product, CBD Golden Milk, with Turmeric, Cinnamon, and Ginger. The MJ BIOTECH, INC. Tea products with CBD are among our most popular Wellness Products.
The CBD GOLDEN MILK and the new line of our CBD Creamers-both – Powdered - and in-development - LIQUID form of CBD CREAMERS, is a very exciting and unique market opportunity for MJBIOTECH CBD line of products. MJ Biotech also offers a line of Organic CBD enhanced Teas Oolong, Jasmine and Rooibos.
These products can be seen at the corporate website www.mjbiotech.us and also at our subsidiary website www.mjsyndicated.com.These new products are being sold initially through outlets in Florida and online at https://mjbiotech.myshopify.com.
Additional partnerships are being negotiated and national distributor agreements proposed.
What is CBD:
The CBD product contains less than 0.3% THC, it is classified as Hemp under Federal Law, and is, therefore, legal to possess and distribute.
CBD may have the potential to treat a wide range of conditions such as anxiety, high blood pressure, skin issues, and chronic pain.
Latest news on CBD: CBD and Parkinson’s Disease: Research on CBD, THC, and THCV has demonstrated that Cannabis medicine may help to manage PD symptoms.
https://www.projectcbd.org/science/cannabis-pharmacology/cbd-and-parkinsons-disease
Safe Harbor Statement:
This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as "would," "may," "will," "expects," and other terms with similar meaning. Forward-looking statements are based on current beliefs, assumptions and expectations and speak only as of the date of this release and involve risks and uncertainties that could cause actual results to differ materially from current expectations. We assume no obligation to update or revise any forward-looking statement, whether because of new information, future events or any other reason.